ADC Reviews

Category: ADC Technologies

targeting MYC

The future of drugs targeting MYC

The transcription factor family consists of c-MYC, L-MYC and N-MYC, which are the main regulators of cellular processes such as cell proliferation, cell differentiation, cell

Read More »
ADCC-2

ADCC targeting mechanism of CD16a

Antibody-dependent cell-mediated cytotoxicity (ADCC) is a potent mechanism of cytotoxicity, mainly mediated by natural killer (NK) cells. When specific antibodies bind to the targeted cell

Read More »
adc-drugs

Endocytosis of ADC drugs

Antibodies of ADC drugs are antibodies targeting tumor cell antigens, which are linked to small-molecule drug poisons through linkers to kill tumor cells and surrounding

Read More »

What is CAR-NK therapy

Foreword Chimeric antigen receptor (CARs)-based T-cell therapy has shown great success against blood cancers; however, potential lethal toxicity (eg, cytokine release syndrome) and high cost

Read More »
adc

Factors Affecting ADC PK

Antibody drug conjugates (ADCs) are complex molecules in which monoclonal antibodies and cytotoxic drugs (small molecule payloads) are linked by linkers to form conjugates. In

Read More »

Latest Articles

Hot Articles